The relationship between the Doha Declaration on the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) and the Convention on Biological Diversity represents one of the most significant debates in international intellectual property law, environmental law, and global trade governance. Both legal instruments address important but sometimes competing concerns relating to innovation, access to biological resources, traditional knowledge, public health, environmental conservation, and equitable sharing of benefits arising from the utilization of genetic resources.
The TRIPS Agreement, administered by the World Trade Organization, establishes minimum standards for protection and enforcement of intellectual property rights among WTO member states, including patents, trademarks, copyrights, geographical indications, and industrial designs. The Convention on Biological Diversity, adopted during the Earth Summit at Rio de Janeiro in 1992 under the framework of the United Nations, focuses on conservation of biological diversity, sustainable use of biological resources, and fair and equitable sharing of benefits arising out of the utilization of genetic resources.
The interaction between these two international regimes became particularly controversial because developing countries argued that strong patent protection under TRIPS could facilitate biopiracy and commercial exploitation of biological resources and traditional knowledge originating from biodiversity-rich countries without fair compensation or consent. The Doha Declaration adopted in 2001 during the WTO Ministerial Conference at Doha played a crucial role in clarifying the relationship between intellectual property protection, public interest concerns, and the broader objectives of sustainable development.
Although the Doha Declaration is best known for its emphasis on public health and access to medicines, it also addressed the relationship between TRIPS and the CBD, particularly in relation to traditional knowledge, genetic resources, and prevention of misappropriation. Developing countries including India strongly advocated harmonization between TRIPS obligations and CBD principles to ensure that intellectual property rights do not undermine biodiversity conservation or exploit indigenous communities and local knowledge systems. India’s position in international negotiations has consistently emphasized the need for disclosure of origin of biological resources and traditional knowledge in patent applications, prior informed consent of local communities, and equitable benefit-sharing mechanisms.
These principles are reflected in Indian domestic legislation such as the Biological Diversity Act, 2002 and the Patents Act, 1970. The relationship between the Doha Declaration and the CBD therefore reflects broader tensions between commercial intellectual property protection and the rights of developing countries over their natural resources, biodiversity, and traditional knowledge systems.
The Convention on Biological Diversity introduced a major shift in international environmental law by recognizing the sovereign rights of states over their biological resources and establishing obligations concerning conservation, sustainable use, and benefit-sharing. Article 3 of the CBD affirms that states have sovereign rights to exploit their own natural resources pursuant to their environmental policies. Article 15 further recognizes national sovereignty over genetic resources and provides that access to such resources shall be subject to prior informed consent and mutually agreed terms.
The CBD also acknowledges the importance of protecting traditional knowledge associated with biodiversity, particularly knowledge held by indigenous and local communities. Article 8(j) specifically requires parties to respect, preserve, and maintain knowledge, innovations, and practices of indigenous and local communities relevant for conservation and sustainable use of biodiversity. However, concerns emerged because the TRIPS Agreement did not initially contain explicit provisions addressing traditional knowledge, genetic resources, disclosure of origin, or benefit-sharing obligations. Critics argued that patent systems under TRIPS enabled companies and researchers from developed countries to obtain patents based on biological resources or traditional medicinal knowledge originating from developing countries without obtaining consent or sharing economic benefits.
This phenomenon became widely described as “biopiracy.” India experienced several controversies involving patents granted abroad relating to neem, turmeric, and basmati rice, where foreign entities attempted to claim proprietary rights over products and knowledge long associated with Indian traditional practices. These incidents significantly influenced India’s advocacy for stronger protection of traditional knowledge and harmonization between TRIPS and CBD obligations.
The Doha Declaration recognized the importance of examining the relationship between TRIPS and the CBD and instructed the TRIPS Council to address issues concerning protection of traditional knowledge and folklore. Paragraph 19 of the Doha Ministerial Declaration specifically directed the TRIPS Council to examine the relationship between the TRIPS Agreement and the CBD, including protection of traditional knowledge and folklore.
This marked an important acknowledgment by the WTO that intellectual property law cannot operate independently from broader environmental and developmental concerns. India and several developing countries subsequently proposed amendments to the TRIPS Agreement requiring patent applicants to disclose the source and origin of biological materials and associated traditional knowledge used in inventions.
They also advocated mandatory proof of prior informed consent and equitable benefit-sharing as conditions for patentability. Indian law already incorporates some of these principles through Section 10 of the Patents Act, which requires disclosure of the source and geographical origin of biological material used in inventions, and Section 3(p), which excludes from patentability inventions that are traditional knowledge or aggregation of known properties of traditionally known components. The Biological Diversity Act, 2002 further regulates access to biological resources and associated knowledge by foreign entities through approval mechanisms administered by the National Biodiversity Authority. These provisions demonstrate India’s attempt to implement CBD principles within its intellectual property framework while complying with TRIPS obligations.
The relationship between the Doha Declaration and the CBD continues to shape international debates concerning intellectual property rights, biodiversity governance, traditional knowledge protection, and sustainable development. One of the central legal and policy challenges involves balancing incentives for innovation with protection of biodiversity-rich countries and indigenous communities from exploitation. Developed countries have often resisted mandatory disclosure requirements in patent applications, arguing that patent systems should not become instruments for enforcing biodiversity-related obligations. In contrast, developing countries argue that absence of disclosure requirements facilitates misappropriation of genetic resources and traditional knowledge without accountability or benefit-sharing.
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization adopted under the CBD in 2010 further strengthened the international framework relating to access and benefit-sharing. The Protocol establishes obligations concerning prior informed consent, mutually agreed terms, and compliance measures for utilization of genetic resources and associated traditional knowledge. India became a party to the Nagoya Protocol and incorporated several of its principles through domestic biodiversity regulation.
The Doha Declaration also contributed significantly to broader recognition that intellectual property rights should be interpreted and implemented consistently with public interest objectives and sustainable development concerns. This principle was strongly reflected in the Doha Declaration on TRIPS and Public Health, which affirmed the right of WTO members to protect public health and promote access to medicines. Similar reasoning supports arguments that TRIPS implementation should not undermine biodiversity conservation or rights of indigenous communities.
The evolving relationship between TRIPS and the CBD further demonstrates increasing interaction between international trade law, environmental law, human rights law, and indigenous rights frameworks. Modern intellectual property governance increasingly recognizes that innovation systems must operate consistently with environmental sustainability, social justice, and equitable development. India has emerged as one of the leading advocates for protection of traditional knowledge and prevention of biopiracy at international forums. Initiatives such as the Traditional Knowledge Digital Library (TKDL) were developed to document traditional medicinal knowledge and prevent wrongful patent claims abroad.
The WTO, World Intellectual Property Organization, and CBD frameworks continue to discuss legal mechanisms for protecting traditional knowledge, genetic resources, and cultural heritage within international intellectual property systems. In conclusion, the relationship between the Doha Declaration on the TRIPS Agreement and the Convention on Biological Diversity reflects a complex and evolving effort to reconcile intellectual property protection with biodiversity conservation, traditional knowledge protection, public interest concerns, and equitable benefit-sharing. The Doha Declaration acknowledged the importance of addressing the interaction between TRIPS and the CBD and opened the way for greater consideration of environmental and developmental issues within international trade law.
India’s legal framework, particularly the Patents Act, 1970 and the Biological Diversity Act, 2002, demonstrates attempts to harmonize intellectual property rights with biodiversity protection and sovereign control over genetic resources. As globalization, biotechnology, and commercialization of biological resources continue to expand, the relationship between TRIPS, the CBD, and the Doha Declaration will remain central to international legal debates concerning sustainability, innovation, and global justice.
Leave a Reply